An Audit of the Use of Cabazitaxel for the Treatment of Metastatic Castrate Resistant Prostate Cancer (mCRPC) Compared with Previous Experience with ECarboF (Epirubicin, Carboplatin and 5-fluorouracil) in a Single Institution
Al-Bakir, M., Williams, S., Davda, R., Mascoll, J., Lynch, C., Mitra, A., Payne, H., Dickson, J., Harland, S., Lopes, A., McGovern, U., Chau, N.-M., Linch, M.Volume:
28
Language:
english
Journal:
Clinical Oncology
DOI:
10.1016/j.clon.2015.12.009
Date:
May, 2016
File:
PDF, 52 KB
english, 2016